Zimmer Biomet receives FDA clearance for ROSA Hip System

ROSA Hip is the fourth robotic system introduced by Zimmer Biomet and adds to the Company's comprehensive ROSA Robotics portfolio, which includes the ROSA Knee System for total knee arthroplasty, ROSA Partial Knee System for partial knee arthroplasty and ROSA ONE for neurosurgical and spine procedures.

ROSA Hip is the newest addition to ZBEdge, Zimmer Biomet's suite of integrated digital and robotic technologies purposefully engineered to deliver transformative data-powered clinical insights, shared seamlessly across the patient journey, and with the goal of improving patient outcomes.

Designed to seamlessly adapt to a surgeon's existing workflow, ROSA Hip aims to assist direct anterior surgeons with preparation, positioning and component impaction, while intra-operatively quantifying cup orientation, leg length and offset. Intra-operative data collected by ROSA Hip is combined with pre- and post-operative data collected by mymobility with Apple Watch, a proprietary remote care management platform, and it is seamlessly consolidated and analyzed by OrthoIntel Orthopedic Intelligence Platform, which is designed to uncover new clinical insights throughout the episode of care and help surgeons and care teams make informed decisions and optimize patient care..